Overview: Why Attitudes Toward Antipsychotic Polypharmacy Matter Antipsychotic polypharmacy (APP) — the concomitant use of two or more antipsychotic drugs — remains a contentious issue in schizophrenia management. While some guidelines advise caution and careful monitoring, others acknowledge tailored approaches when monotherapy fails. Understanding what shapes psychiatrists’ attitudes toward APP is essential because clinician preferences…